Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis

Chih Ming Ho, Tzu-Bi Shih, Chih Chiang Hsiao, Shih Hung Huang, Shwu-Fen Chang, W. F. Cheng

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: This study aimed to investigate whether the DNA methylation of human ovarian carcinoma stromal progenitor cells (OCSPCs) could promote the tumorigenesis of ovarian carcinoma. Methods: OCSPCs were first isolated from fresh tumor tissues and ascites of ovarian cancer patients. In vivo and in vitro experiments on the effect of the OCSPCs on tumorigenesis and the effects of DNA demethylation on the OCSPCs were then performed. Results: The OCSPCs possessed self-renewal and multipotent differentiation capacity with elevated expressions of OCT4, NANOG, BMP2, BMP4, Rex-1, AC133 and TGF-β. The OCSPCs, when combined with tumor cells in vivo could promote tumor growth. The methylation profiles of tumor suppressor genes (TSGs) were significantly higher in the OCSPCs than in ovarian cancer cells (p <0.001). 5-aza-2-dC could alter the methylation levels of TSGs in OCSPCs and also inhibit the tumor promoting capabilities of the OCSPCs by decreasing the proliferation of tumors cells. The expression levels of TSGs were re-expressed by 5-aza-2-dC to inhibit the self-renewal and growth of OCSPCs. Conclusions: OCSPCs with decreased TSG expressions in the ovarian tumor microenvironment were able to promote tumorigenesis which could be reversed by DNA demethylation. DNA demethylation reversing the expression of TSGs in OCSPCs may represent a potential therapeutic target for ovarian cancer.

Original languageEnglish
Article number367
JournalJournal of Translational Medicine
Volume13
Issue number1
DOIs
Publication statusPublished - Nov 23 2015

Fingerprint

Methylation
Stromal Cells
Tumors
Carcinogenesis
Stem Cells
Genes
Carcinoma
Tumor Suppressor Genes
Ovarian Neoplasms
Cells
Neoplasms
DNA
Tumor Microenvironment
Gene expression
DNA Methylation
Growth
Ascites
Tissue

Keywords

  • 5-aza-2-deoxycytidine
  • Methylation
  • Ovarian carcinoma stromal progenitor cells
  • Tumor suppressor genes
  • Tumorigenesis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis. / Ho, Chih Ming; Shih, Tzu-Bi; Hsiao, Chih Chiang; Huang, Shih Hung; Chang, Shwu-Fen; Cheng, W. F.

In: Journal of Translational Medicine, Vol. 13, No. 1, 367, 23.11.2015.

Research output: Contribution to journalArticle

Ho, Chih Ming ; Shih, Tzu-Bi ; Hsiao, Chih Chiang ; Huang, Shih Hung ; Chang, Shwu-Fen ; Cheng, W. F. / Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis. In: Journal of Translational Medicine. 2015 ; Vol. 13, No. 1.
@article{06b373fcfb804749ba68cd1b49f6e41f,
title = "Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis",
abstract = "Background: This study aimed to investigate whether the DNA methylation of human ovarian carcinoma stromal progenitor cells (OCSPCs) could promote the tumorigenesis of ovarian carcinoma. Methods: OCSPCs were first isolated from fresh tumor tissues and ascites of ovarian cancer patients. In vivo and in vitro experiments on the effect of the OCSPCs on tumorigenesis and the effects of DNA demethylation on the OCSPCs were then performed. Results: The OCSPCs possessed self-renewal and multipotent differentiation capacity with elevated expressions of OCT4, NANOG, BMP2, BMP4, Rex-1, AC133 and TGF-β. The OCSPCs, when combined with tumor cells in vivo could promote tumor growth. The methylation profiles of tumor suppressor genes (TSGs) were significantly higher in the OCSPCs than in ovarian cancer cells (p <0.001). 5-aza-2-dC could alter the methylation levels of TSGs in OCSPCs and also inhibit the tumor promoting capabilities of the OCSPCs by decreasing the proliferation of tumors cells. The expression levels of TSGs were re-expressed by 5-aza-2-dC to inhibit the self-renewal and growth of OCSPCs. Conclusions: OCSPCs with decreased TSG expressions in the ovarian tumor microenvironment were able to promote tumorigenesis which could be reversed by DNA demethylation. DNA demethylation reversing the expression of TSGs in OCSPCs may represent a potential therapeutic target for ovarian cancer.",
keywords = "5-aza-2-deoxycytidine, Methylation, Ovarian carcinoma stromal progenitor cells, Tumor suppressor genes, Tumorigenesis",
author = "Ho, {Chih Ming} and Tzu-Bi Shih and Hsiao, {Chih Chiang} and Huang, {Shih Hung} and Shwu-Fen Chang and Cheng, {W. F.}",
year = "2015",
month = "11",
day = "23",
doi = "10.1186/s12967-015-0722-7",
language = "English",
volume = "13",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis

AU - Ho, Chih Ming

AU - Shih, Tzu-Bi

AU - Hsiao, Chih Chiang

AU - Huang, Shih Hung

AU - Chang, Shwu-Fen

AU - Cheng, W. F.

PY - 2015/11/23

Y1 - 2015/11/23

N2 - Background: This study aimed to investigate whether the DNA methylation of human ovarian carcinoma stromal progenitor cells (OCSPCs) could promote the tumorigenesis of ovarian carcinoma. Methods: OCSPCs were first isolated from fresh tumor tissues and ascites of ovarian cancer patients. In vivo and in vitro experiments on the effect of the OCSPCs on tumorigenesis and the effects of DNA demethylation on the OCSPCs were then performed. Results: The OCSPCs possessed self-renewal and multipotent differentiation capacity with elevated expressions of OCT4, NANOG, BMP2, BMP4, Rex-1, AC133 and TGF-β. The OCSPCs, when combined with tumor cells in vivo could promote tumor growth. The methylation profiles of tumor suppressor genes (TSGs) were significantly higher in the OCSPCs than in ovarian cancer cells (p <0.001). 5-aza-2-dC could alter the methylation levels of TSGs in OCSPCs and also inhibit the tumor promoting capabilities of the OCSPCs by decreasing the proliferation of tumors cells. The expression levels of TSGs were re-expressed by 5-aza-2-dC to inhibit the self-renewal and growth of OCSPCs. Conclusions: OCSPCs with decreased TSG expressions in the ovarian tumor microenvironment were able to promote tumorigenesis which could be reversed by DNA demethylation. DNA demethylation reversing the expression of TSGs in OCSPCs may represent a potential therapeutic target for ovarian cancer.

AB - Background: This study aimed to investigate whether the DNA methylation of human ovarian carcinoma stromal progenitor cells (OCSPCs) could promote the tumorigenesis of ovarian carcinoma. Methods: OCSPCs were first isolated from fresh tumor tissues and ascites of ovarian cancer patients. In vivo and in vitro experiments on the effect of the OCSPCs on tumorigenesis and the effects of DNA demethylation on the OCSPCs were then performed. Results: The OCSPCs possessed self-renewal and multipotent differentiation capacity with elevated expressions of OCT4, NANOG, BMP2, BMP4, Rex-1, AC133 and TGF-β. The OCSPCs, when combined with tumor cells in vivo could promote tumor growth. The methylation profiles of tumor suppressor genes (TSGs) were significantly higher in the OCSPCs than in ovarian cancer cells (p <0.001). 5-aza-2-dC could alter the methylation levels of TSGs in OCSPCs and also inhibit the tumor promoting capabilities of the OCSPCs by decreasing the proliferation of tumors cells. The expression levels of TSGs were re-expressed by 5-aza-2-dC to inhibit the self-renewal and growth of OCSPCs. Conclusions: OCSPCs with decreased TSG expressions in the ovarian tumor microenvironment were able to promote tumorigenesis which could be reversed by DNA demethylation. DNA demethylation reversing the expression of TSGs in OCSPCs may represent a potential therapeutic target for ovarian cancer.

KW - 5-aza-2-deoxycytidine

KW - Methylation

KW - Ovarian carcinoma stromal progenitor cells

KW - Tumor suppressor genes

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84959095336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959095336&partnerID=8YFLogxK

U2 - 10.1186/s12967-015-0722-7

DO - 10.1186/s12967-015-0722-7

M3 - Article

C2 - 26597084

AN - SCOPUS:84959095336

VL - 13

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 367

ER -